Details for New Drug Application (NDA): 091558
✉ Email this page to a colleague
The generic ingredient in MYCOPHENOLIC SODIUM is mycophenolic sodium. There are seventeen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the mycophenolic sodium profile page.
Summary for 091558
Tradename: | MYCOPHENOLIC SODIUM |
Applicant: | Apotex Inc |
Ingredient: | mycophenolic sodium |
Patents: | 0 |
Suppliers and Packaging for NDA: 091558
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 091558 | ANDA | Major Pharmaceuticals | 0904-6785 | 0904-6785-04 | 30 BLISTER PACK in 1 CARTON (0904-6785-04) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK |
MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 091558 | ANDA | Major Pharmaceuticals | 0904-6785 | 0904-6785-61 | 100 BLISTER PACK in 1 CARTON (0904-6785-61) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 180MG BASE | ||||
Approval Date: | Aug 21, 2012 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, DELAYED RELEASE;ORAL | Strength | EQ 360MG BASE | ||||
Approval Date: | Aug 19, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription